Ryan K. Shields

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Ryan K. Shields, M. Hong Nguyen, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 487 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne <i>bla</i> _KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

Ryan K. Shields, Liang Chen, Shaoji Cheng et al. · Antimicrobial Agents and Chemotherapy · 2016 · 485 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Ryan K. Shields, Brian A. Potoski, Ghady Haidar et al. · Clinical Infectious Diseases · 2016 · 428 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

Zubair Qureshi, Lauren Hittle, Jessica A. O’Hara et al. · Clinical Infectious Diseases · 2015 · 400 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Performance of Candida Real-time Polymerase Chain Reaction,  -D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

M. Hong Nguyen, Mark Wissel, Ryan K. Shields et al. · Clinical Infectious Diseases · 2012 · 294 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17